Immunopathological and Modulatory Effects of Cag A+ Genotype on Gastric Mucosa, Inflammatory Response, Pepsinogens, and Gastrin-17 Secretion in Iraqi Patients infected with H. pylori

Authors

DOI:

https://doi.org/10.3889/oamjms.2018.178

Keywords:

pepsinogens, gastrin -17, gastric mucosa, H.pylori, CagA, Iraq

Abstract

OBJECTIVE: To determine the immunopathological correlation between Cag A+ H. pylori-specific IgG; pepsinogen I&II (PI&PII); gastrin-17 (G-17); status of gastric and duodenal mucosa and inflammatory activities on different gastroduodenal disorders.

METHODOLOGY: Eighty gastroduodenal biopsies were taken from patients with gastroduodenal disorders for histopathological evaluation and H. pylori diagnosis. Serum samples were used for evaluation of gastric hormones and detection of H. pylori-specific IgG antibodies. The tissue expression of H. pylori Cag A gene was detected by in situ hybridisation.

RESULTS: H. pylori IgG antibodies were detected in (88.8%) of enrolled patients. According to Cag A gene expression, Significant difference (P value Ë‚ 0.05) was detected in levels of PG I; PGII, PG I/PG II among patients with gastric disorders. Serum G-17 level was negatively correlated with Cag A gene expression (P-value = 0.04). There was a significant correlation between H. pylori IgG and PG I; PG II; G-17. The current study revealed that corpus atrophic gastritis was diagnosed histologically with (5%) gastric ulcer cases; (3.75%) of duodenal ulcer cases; (3.75%) of duodenitis cases; (1.25%) of gastropathy cases and (8.75%) of gastritis cases. At the same time H. pylori gastritis diagnosed concurrently with (8.75%) of gastric ulcer cases; (11.25%) of duodenal ulcer cases; (17.5%) of gastropathy cases; (3.75%) of duodenitis cases and (2.5%) of prepyloric ulcer cases. A significant correlation was reported between the Immunopathological status of gastric mucosa and endoscopic mucosal finding among duodenal ulcer cases and gastritis cases only. A positive correlation was reported between serum levels of PGI; PGII; PGI/PGII; G-17; PMNs grade and Immunopathological status of the gastroduodenal mucosa of H. pylori Infected patients. A significant difference was reported in lymphocyte grades among gastric disorders without correlation with immunohistopathological changes in the mucosa (P-value = 0.002). A significant difference was reported in lymphocyte grades among different disorders according to H. pylori IgG. A significant difference was reported in serum level of PG I; PG II; PG I/PG II; G-17 according to PMN and lymphocyte grades (P-value Ë‚ 0.01). PMNs grades positively correlated with gastric Cag A expression; H. pylori IgG; PG II; G-17 levels. PG I; PG I/ PG II correlated with lymphocyte grades (P-value Ë‚ 0.05); while PGII has a negative correlation (P-value = 0.039).

CONCLUSION: Endoscopic mucosal finding does not reflect exactly the actual immunopathological changes of gastric mucosa during H. pylori infection. Secretion of gastrin was not affected by the presence of Cag A in gastric tissue. Instead, the fluctuation in the hormone level appears to be due to the presence of H. pylori infection in gastric tissue. Gastric tissue infiltration with PMNs & lymphocytes inflammatory infiltrates has a direct effect on PGs and gastrin levels in serum of infected patients. The level of PG I; PG II; G-17 secretion correlated with the development of immune response against H. pylori and production of specific H. pylori IgG. Finally, H. pylori can modulate gastric secretions through Cag A dependent and independent pathways.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Singh R, Laxmi TV, Verma K, Dung R. Chronic Gastritis: Helicobacter pylori Infection: A Clinico-Endoscopic and Histological evaluation. Global Journal For Research Analysis. 2018; 6(2).

Al-Ezzy AIA. Molecular and Immunopathological role of Gastric versus lymphocytes Interleukin 8 Gene Expression in H.pylori induced Fas-Fasl apoptotic pathway in Gastroduodenal Ulcer in Iraqi patients. Journal of Biology, Agriculture and Healthcare. 2015; 5(5):141-153.

Assoumou MO, Noah D, Ngaba G, Bagnaka SE, Alonge I, Paloheimo I, Njoya O. Association between the immune responses against Helicobacter pylori infections and the concentration of atrophic gastric biomarkers in Cameroon. Journal of Applied Medical Sciences. 2012; 1(1):15-26.

AL-Ezzy AIA. Evaluation of Clinicopathological and Risk Factors for Nonmalignant H. Pylori Associated Gastroduodenal Disorders in Iraqi Patients. Open Access Maced J Med Sci. 2015; 3(4):655-660. https://doi.org/10.3889/oamjms.2015.115 PMid:27275303 PMCid:PMC4877903

Al-Ezzy AIA. Molecular and Immunopathological role of nuclear factor k b detected by insitu hybridization in pathogenesis of chronic atrophic gastritis in Iraqi patients. International Journal of Advanced Research. 2014; 2(1):67-78.

Massarrat S, Haj-Sheykholeslami A, Mohamadkhani A, Zendehdel N, Aliasgari A, Rakhshani N, Stolte M, Shahidi SM. Pepsinogen II can be a potential surrogate marker of morphological changes in corpus before and after H. pylori eradication. BioMed research international. 2014; 2014.

Zhang X-m, Li J-x, Zhang G-y, Li X-h, Gu H. The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China. BMC gastroenterology. 2014; 14(1):3. https://doi.org/10.1186/1471-230X-14-3 PMid:24383519 PMCid:PMC3893538

Di Mario FAF, Cavallaro L. A Non-invasive Approach to Diagnosis of Upper Gastrointestinal Diseases: Via Comelico, 2008.

Daugule I, Sudraba A, Chiu H-M, Funka K, Ivanauskas A, Janciauskas D, Jonaitis L, Kiudelis G, Tolmanis I, Vanags A. Gastric plasma biomarkers and Operative Link for Gastritis Assessment gastritis stage. European journal of gastroenterology & hepatology. 2011; 23(4):302-307. https://doi.org/10.1097/MEG.0b013e3283438ac3 PMid:21389862

Song HJ, Jang SJ, Yun S-C, Park YS, Kim M-J, Lee S-M, Choi KD, Lee GH, Jung H-Y, Kim J-H. Low levels of pepsinogen I and pepsinogen I/II ratio are valuable serologic markers for predicting extensive gastric corpus atrophy in patients undergoing endoscopic mucosectomy. Gut and liver. 2010; 4(4):475-480. https://doi.org/10.5009/gnl.2010.4.4.475 PMid:21253295 PMCid:PMC3021602

Serim RC. PyloriTek® For H. pylori In.: http://www.serim.com; 2012.

Balan K, Sa V. Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans. Int J Curr Microbiol App Sci. 2013; 2(7):63-68.

Tzeng J-E, Lin Y-L, Chung S-M, Chu Y-T. Comparison of four diagnostic methods for Helicobacter pylori. Tzu Chi Med J. 2005; 17(5):339-343.

Insitu hybridization detection system [ http:// www.maximbiotech.com ]

Pity IS, Baizeed AM. Identification of Helicobacter pylori in gastric biopsies of patients with chronic gastritis: Histopathological and immunohistochemical study. Duhok Med J. 2011; 5(1):69-77.

AL-Ezzy AIA. Immunopathological Role of FAS-FASL Apoptotic Pathway in H. pylori CagA Positive Associated Chronic Atrophic Gastritis in Iraqi Patients. Journal of Biology, Agriculture and Healthcare. 2014; 4(23):67-74.

Biohit gastro panel

AL-Ezzy AIA. In Situ Nick End Labeling as a Molecular Immunopathological Indicator for the Severity of DNA Fragmentationand Gastroduodenal Tissue Damage among H. Pylori Cag APositive Patients. Indian Journal of Science and Technology. 2016; 9(2).

Kadhim G, Omar H, Ismail A. Risk Factors Associated with Peptic Ulcer Disease. J Bioengineer & Biomedical Sci. 2015; 5(142):2.

Pandya HB, Patel JS, Agravat HH. Non-Invasive Diagnosis of Helicobacter pylori: Evaluation of Two Enzyme Immunoassays, Testing Serum IgG and IgA Response in the Anand District of Central Gujarat, India. Journal of clinical and diagnostic research: JCDR. 2014; 8(6):DC12. https://doi.org/10.7860/JCDR/2014/7578.4480

Reddy BS, Venkateswarlu P, Jyothi BN, Devi AR. Role of H. Pylori In Gastroduodenal Diseases. J of Evolution of Med and Dent Sci. 2015; 4(4):581-586. https://doi.org/10.14260/jemds/2015/86

Ahmed SY, Shammari HNA. Helicobacter pylori Infection: Seroprevalence and Detection of H. Pylori IgG by Using ELISA. International Journal of Immunology. 2015; 3(2):21-26. https://doi.org/10.11648/j.iji.20150302.12

Lorente S, Doiz O, Serrano MT, Castillo J, Lanas A. Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells. Gut. 2002; 50(1):13-18. https://doi.org/10.1136/gut.50.1.13 PMid:11772960 PMCid:PMC1773080

Leja M, Lapina S, Polaka I, Rudzite D, Vilkoite I, Daugule I, Belkovets A, Pimanov S, Makarenko J, Tolmanis I, Lejnieks A. Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy. Medicina. 2014; 50(1):8-13. https://doi.org/10.1016/j.medici.2014.05.001 PMid:25060199

Shiota S, Murakami K, Okimoto T, Kodama M, Yamaoka Y. Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan. Journal of gastroenterology and hepatology. 2014; 29(1):67-73. https://doi.org/10.1111/jgh.12359 PMid:24033876 PMCid:PMC3870047

Lu C, Jia H, Xu A, Tang J, Xu G, Yue W, Zhang J. Helicobacter pylori infection and pepsinogen levels have clinical significance in hypertension patients. International journal of clinical and experimental medicine. 2014; 7(12):5675. PMid:25664089 PMCid:PMC4307536

Shamsdin SA, Saberifiroozi M, Mehrabani D, Heydari ST. Pepsinogen I and II, Gastrin and Cag A Serum Levels in Shiraz. Middle East Journal of Digestive Diseases. 2011; 3(2):103. PMid:25197540 PMCid:PMC4154912

Zhang X, Xue L, Xing L, Wang J, Cui J, Mi J, Xing X, Wang J, Du Z, Misumi J. Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14 year follow up result in a rural Chinese community. International Journal of Cancer. 2012; 130(7):1614-1619. https://doi.org/10.1002/ijc.26172 PMid:21547904

Yanaoka K, Oka M, Ohata H, Yoshimura N, Deguchi H, Mukoubayashi C, Enomoto S, Inoue I, Iguchi M, Maekita T. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. International Journal of Cancer. 2009; 125(11):2697-2703. https://doi.org/10.1002/ijc.24591 PMid:19610064

Honarkar Z, Baladast M, Ardakani E, BJS. Gastrin, Cholecystokinin (CCK) and H. Pylori in Nonulcer Dyspepsia. Sheraz Medical Ejournal. 2007; 8(1):13-21.

Amal HS. The relationship between Helicobacter pylori CagA and antral Gastrin (G) and somatostatin (D) cells in chronic gastritis patients. AL-TAQANI. 2010; 23(5):135-144.

Liu Y, Vosmaer G, Tytgat G, Xiao S, Ten Kate F. Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-associated gastritis. Journal of clinical pathology. 2005; 58(9):927-931. https://doi.org/10.1136/jcp.2003.010710 PMid:16126872 PMCid:PMC1770830

Huang XQ. Helicobacter pylori infection and gastrointestinal hormones: a review. World journal of gastroenterology. 2000; 6(6):783-788. https://doi.org/10.3748/wjg.v6.i6.783 PMid:11819696 PMCid:PMC4728263

Mansour-Ghanaei F, Joukar F, Rajpout Y, Hasandokht T. Screening of Pre-cancerous Gastric Lesions by Serum Pepsinogen, Gastrin-17, Anti-Helicobacter Pylori and Anti-Caga Antibodies in Dyspeptic Patients over 50 years Old in Guilan Province, North of Iran. Asian Pac J Cancer Prey. 2014; 15(18):7635-7638. https://doi.org/10.7314/APJCP.2014.15.18.7635

Garg B, Sandhu V, Sood N, Sood A, Malhotra V. Histopathological analysis of chronic gastritis and correlation of pathological features with each other and with endoscopic findings. Polish Journal of Pathology. 2012; 63(3):172-178. https://doi.org/10.5114/pjp.2012.31501 PMid:23161233

Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Mernova VP, Polyakova MB. Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study. Scandinavian journal of Gastroenterology. 2005; 40(3):297-301. https://doi.org/10.1080/00365520410010607 PMid:15932170

Salimzadeh L, Bagheri N, Zamanzad B, Azadegan-Dehkordi F, Rahimian G, Hashemzadeh-Chaleshtori M, Rafieian-Kopaei M, Sanei MH, Shirzad H. Frequency of virulence factors in Helicobacter pylori-infected patients with gastritis. Microbial Pathogenesis. 2015; 80(0):67-72. https://doi.org/10.1016/j.micpath.2015.01.008 PMid:25656240

Haj sheykholeslami A, Rakhshani N, Amirzargar A, Rafiee R, Shahidi SM, Nikbin B, Khosravi F, Massarrat S. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis. Clinical Gastroenterology and Hepatology. 2008; 6(2):174-179. https://doi.org/10.1016/j.cgh.2007.11.016 PMid:18237867

Chuang C, Sheu B, Yang H, Kao A, Cheng H, Yao W. Hypergastrinemia after Helicobacter pylori infection is associated with bacterial load and related inflammation of the oxyntic corpus mucosa. Journal of Gastroenterology and Hepatology. 2004; 19(9):988–993. https://doi.org/10.1111/j.1440-1746.2004.03416.x PMid:15304114

Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer. Journal of gastroenterology and hepatology. 2008; 23(11):1666-1671. https://doi.org/10.1111/j.1440-1746.2007.04983.x PMid:17559360

Published

2018-05-14

How to Cite

1.
AL-Ezzy AIA. Immunopathological and Modulatory Effects of Cag A+ Genotype on Gastric Mucosa, Inflammatory Response, Pepsinogens, and Gastrin-17 Secretion in Iraqi Patients infected with H. pylori. Open Access Maced J Med Sci [Internet]. 2018 May 14 [cited 2024 Mar. 28];6(5):794-802. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2018.178

Issue

Section

B - Clinical Sciences

Most read articles by the same author(s)